Protective role of selenium against the toxicity of multi-drug chemotherapy in patients with ovarian cancer.

K Sieja

Journal: Die Pharmazie 2001;55(12):958-9

PMID: 11189880

Abstract

Address: Department of Pharmacology and Toxicology and Department of Gynecological Surgery and Oncology of Adults and Children, Pomeranian Medical University, Szczecin, Poland.

Link outs

Free resources

Medical:

https://medlineplus.gov/ovariancancer.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Blood Cell Count, Female, Humans, Middle Aged, Ovarian Neoplasms, Selenium

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.